Елена Евгеньевна Баженова
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Елена Евгеньевна Баженова has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Наталья Николаевна Касьянова
Орловский государственный университет имени И.С. Тургенева, Орёл, России
2 shared publications - Andrei Dmitrievich Kaprin
National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, Koroleva St. 4, 249036 Obninsk, Russia
1 shared publication - D. A. Kolodina
Pavlov University
1 shared publication - D. A. Raushkin
P. A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Research Center of Radiology
1 shared publication - E.A. Poygina1 shared publication
- Elena A. Klesareva
Chazov National Medical Research Center of Cardiology
1 shared publication
Latest Publications
- 25 September 2026
- Published by Orel State University in Modern society and law
- Vol. 17 (4 (83)) , 3-16
Legal framework, mechanisms, and analysis of the development of volunteer activity in higher education institutions
- 25 September 2026
- Published by Orel State University in Modern society and law
- Vol. 17 (4 (83)) , 3-16
Legal framework, mechanisms, and analysis of the development of volunteer activity in higher education institutions
- 25 September 2026
- Published by Orel State University in Modern society and law
- Vol. 17 (4 (83))
Legal framework, mechanisms, and analysis of the development of volunteer activity in higher education institutions
- 25 September 2026
- Published by Orel State University in Modern society and law
- Vol. 17 (4 (83))
Legal framework, mechanisms, and analysis of the development of volunteer activity in higher education institutions
- 1 January 2025
- Published by NP Rusmedical Group in Therapist’s Bulletin
Clinical observation of the patient with extra-articular manifestations of rheumatoid arthritis (rheumatoid nodules in the lungs)
Aim. Demonstration of clinical observation of a patient with a long-term history of rheumatoid arthritis with extra-articular manifestations (rheumatoid nodules in the lungs) and comorbid pathology. Key points. Rheumatoid nodules in the lungs are one of the rarest extraarticular manifestations of rheumatoid arthritis. Most often they are asymptomatic, and in most cases their specific treatment is not required. However, when they are detected, it is necessary to conduct a differential diagnosis to exclude a number of diseases (tuberculosis, neoplasia, etc.) and choose the right tactics for managing the patient. Conclusion. Differential diagnosis of lung lesions in patients with rheumatoid arthritis, including the differentiation of infectious (tuberculosis, etc.) and non-infectious (oncological diseases, etc.) processes, remains a difficult clinical task. It requires a comprehensive interdisciplinary approach: assessment of the risk of malignancy of the process, dynamic monitoring, consultations of various specialists. At the same time, a lung biopsy is not a routine diagnostic method. Keywords: rheumatoid arthritis, rheumatoid nodules, differential diagnosis, extraarticular manifestations.
- 1 January 2025
- Published by NP Rusmedical Group in Therapist’s Bulletin
Clinical observation of the patient with extra-articular manifestations of rheumatoid arthritis (rheumatoid nodules in the lungs)
Aim. Demonstration of clinical observation of a patient with a long-term history of rheumatoid arthritis with extra-articular manifestations (rheumatoid nodules in the lungs) and comorbid pathology. Key points. Rheumatoid nodules in the lungs are one of the rarest extraarticular manifestations of rheumatoid arthritis. Most often they are asymptomatic, and in most cases their specific treatment is not required. However, when they are detected, it is necessary to conduct a differential diagnosis to exclude a number of diseases (tuberculosis, neoplasia, etc.) and choose the right tactics for managing the patient. Conclusion. Differential diagnosis of lung lesions in patients with rheumatoid arthritis, including the differentiation of infectious (tuberculosis, etc.) and non-infectious (oncological diseases, etc.) processes, remains a difficult clinical task. It requires a comprehensive interdisciplinary approach: assessment of the risk of malignancy of the process, dynamic monitoring, consultations of various specialists. At the same time, a lung biopsy is not a routine diagnostic method. Keywords: rheumatoid arthritis, rheumatoid nodules, differential diagnosis, extraarticular manifestations.
- Open Access
- 26 January 2022
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 21 (2) , 3164
Telehealth consultations in cardio-oncology
Aim . To evaluate the role of a cardiologist in telehealth counseling of cancer patients at the federal oncology center. Material and methods . This retrospective study was conducted based on the materials of 215 telehealth consultations on cardiooncology, performed in the period from January 2019 to September 2021. Data on referrals to a cardiologist (cardio-oncologist) from various Russian regions and consultants’ answers were analyzed, taking into account the following data: region, sex, age of a patient, cancer type, stage, participation of other consultants, type of cardiovascular disease, the need for additional information and features of treatment — surgery, chemotherapy, radiation therapy. Risk was stratified based on a checklist including the main risk factors for cardiotoxicity. The recommendations of consultants for monitoring patients, as well as drug therapy prescriptions, were analyzed. Results . The most common cancer sites in patients referred for telehealth consultations on cardio-oncology were lungs, larynx and trachea, colon and rectum, kidneys and bladder, ovaries and uterus, and stomach. Cardiologists consulted together with oncologists — surgeons, medical oncologists, as well as anesthesiologists and radiation oncologists. The most common cardiovascular diseases were hypertension — 80,9% of patients, heart failure — 60%, arrhythmias — 41,6% and coronary heart disease — 37,7%. From 71 to 80,3%, 15,6-21% and 3,9-7,8% of patients had preserved, mid-range and reduced left ventricular ejection fraction. In 47,6-66,7% of cases, consultants required additional information. Based on risk stratification of cardiotoxicity of anticancer treatment, 118 (81,9%) patients out of 144 were classified as high and very high risk. Most patients were recommended cardioprotective therapy, which most often included angiotensin-converting enzyme inhibitors/angiotensin receptor blockers — 43,1-53,1%, beta-blockers — 44,8-58,6%, and statins — 22,4-38,3%. An algorithm for creating a request for a cardio-oncology telehealth consultation has been developed. Conclusion . The important role of cardio-oncology telehealth consultations in the work of the federal oncology center is demonstrated. Consulting cardiologists are part of a single multidisciplinary team of specialists and must act taking into account the characteristics of cancer and antitumor therapy prescribed by oncologists.
- 26 January 2022
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 21 (2) , 3164
Open AccessTelehealth consultations in cardio-oncology
Aim . To evaluate the role of a cardiologist in telehealth counseling of cancer patients at the federal oncology center. Material and methods . This retrospective study was conducted based on the materials of 215 telehealth consultations on cardiooncology, performed in the period from January 2019 to September 2021. Data on referrals to a cardiologist (cardio-oncologist) from various Russian regions and consultants’ answers were analyzed, taking into account the following data: region, sex, age of a patient, cancer type, stage, participation of other consultants, type of cardiovascular disease, the need for additional information and features of treatment — surgery, chemotherapy, radiation therapy. Risk was stratified based on a checklist including the main risk factors for cardiotoxicity. The recommendations of consultants for monitoring patients, as well as drug therapy prescriptions, were analyzed. Results . The most common cancer sites in patients referred for telehealth consultations on cardio-oncology were lungs, larynx and trachea, colon and rectum, kidneys and bladder, ovaries and uterus, and stomach. Cardiologists consulted together with oncologists — surgeons, medical oncologists, as well as anesthesiologists and radiation oncologists. The most common cardiovascular diseases were hypertension — 80,9% of patients, heart failure — 60%, arrhythmias — 41,6% and coronary heart disease — 37,7%. From 71 to 80,3%, 15,6-21% and 3,9-7,8% of patients had preserved, mid-range and reduced left ventricular ejection fraction. In 47,6-66,7% of cases, consultants required additional information. Based on risk stratification of cardiotoxicity of anticancer treatment, 118 (81,9%) patients out of 144 were classified as high and very high risk. Most patients were recommended cardioprotective therapy, which most often included angiotensin-converting enzyme inhibitors/angiotensin receptor blockers — 43,1-53,1%, beta-blockers — 44,8-58,6%, and statins — 22,4-38,3%. An algorithm for creating a request for a cardio-oncology telehealth consultation has been developed. Conclusion . The important role of cardio-oncology telehealth consultations in the work of the federal oncology center is demonstrated. Consulting cardiologists are part of a single multidisciplinary team of specialists and must act taking into account the characteristics of cancer and antitumor therapy prescribed by oncologists.
- Open Access
- 9 September 2018
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- No. 8,p. 13-20
RAISED IgM AUTOANTIBODY TITER TO LIPOPROTEIDE(A) AS ANTIATHEROGENIC FACTOR IN SEVERE HYPERCHOLESTEROLEMIA PATIENTS
Aim.To investigate on the relation of lipoproteide(a) (Lpa), subfractions of atherogenic lipoproteides and titers of specific autoantibodies (autoAb) with the presence and severity of carotid arteries (CA) lesion in statin-naïve patients with severe hypercholesterolemia.Materialandmethods.To the study, 133 statin-naïve patients included, age 18 to 75 y.o., with absent clinical signs of coronary heart disease, and with first time diagnosed severe hypercholesterolemia (total cholesterol >7,5 mM/L and/or low density lipoproteides cholesterol >4,9 mM/L) with ultrasound duplex scan data of CA. All patients underwent measurement of Lpa concentration, lipid profile, subfractional content of apoB-100-containing lipoproteides and autoAb titer against them.Results.According to the data from duplex CA scan, patients were selected to 2 groups: control group (n=76) with no CA atherosclerosis; main group — patients with CA stenosis >20% (n=57). The participants of main group were older than controls, with no other clinical or lipid profile differences. Titre of autoAb IgM specific for Lpa and its oxidized modifications was significantly lower in CA atherosclerosis comparing to controls. The grade of CA stenosis in severe hypercholesterolemia patients positively correlated with age (r=0,24, p=0,005) and negatively — with autoAb IgM to apoB100-containing lipoproteides (r=-0,28 and r=-0,26, pConclusion.In patients with severe hypercholesterolemia Lpa is an autoantigen, and IgM autoantibodies to Lpa play antiatherogenic role.
- 9 September 2018
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- No. 8,p. 13-20
Open AccessRAISED IgM AUTOANTIBODY TITER TO LIPOPROTEIDE(A) AS ANTIATHEROGENIC FACTOR IN SEVERE HYPERCHOLESTEROLEMIA PATIENTS
Aim.To investigate on the relation of lipoproteide(a) (Lpa), subfractions of atherogenic lipoproteides and titers of specific autoantibodies (autoAb) with the presence and severity of carotid arteries (CA) lesion in statin-naïve patients with severe hypercholesterolemia.Materialandmethods.To the study, 133 statin-naïve patients included, age 18 to 75 y.o., with absent clinical signs of coronary heart disease, and with first time diagnosed severe hypercholesterolemia (total cholesterol >7,5 mM/L and/or low density lipoproteides cholesterol >4,9 mM/L) with ultrasound duplex scan data of CA. All patients underwent measurement of Lpa concentration, lipid profile, subfractional content of apoB-100-containing lipoproteides and autoAb titer against them.Results.According to the data from duplex CA scan, patients were selected to 2 groups: control group (n=76) with no CA atherosclerosis; main group — patients with CA stenosis >20% (n=57). The participants of main group were older than controls, with no other clinical or lipid profile differences. Titre of autoAb IgM specific for Lpa and its oxidized modifications was significantly lower in CA atherosclerosis comparing to controls. The grade of CA stenosis in severe hypercholesterolemia patients positively correlated with age (r=0,24, p=0,005) and negatively — with autoAb IgM to apoB100-containing lipoproteides (r=-0,28 and r=-0,26, pConclusion.In patients with severe hypercholesterolemia Lpa is an autoantigen, and IgM autoantibodies to Lpa play antiatherogenic role.